Adenoviral transduction of human ‘clinical grade’ immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity
- 1 July 2000
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 241 (1-2) , 69-81
- https://doi.org/10.1016/s0022-1759(00)00214-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Human PBMC-derived dendritic cells transduced with an adenovirus vector induce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitroGene Therapy, 1999
- Generation of phagocytic MAK and MAC-DC for therapeutic use: Characterization and in vitro functional propertiesExperimental Hematology, 1999
- Efficient Gene Delivery into Human Dendritic Cells by Adenovirus Polyethylenimine and Mannose Polyethylenimine TransfectionHuman Gene Therapy, 1999
- Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cellsGene Therapy, 1997
- Generation of Dendritic Cells In Vitro From Peripheral Blood Mononuclear Cells With Granulocyte-Macrophage-Colony-Stimulating Factor, Interleukin-4, and Tumor Necrosis Factor-α for Use in Cancer ImmunotherapyAnnals of Surgery, 1997
- Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicabilityJournal of Immunological Methods, 1996
- Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsNature Medicine, 1996
- Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in VivoScience, 1991
- Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccineJournal of General Virology, 1990
- An improved method for the fractionation of human blood cells by centrifugal elutriationAnalytical Biochemistry, 1980